Serum anti-müllerian hormone levels in women with secondary amenorrhea.
Anti-müllerian hormone (AMH) appears to regulate follicular growth. The aim of this study was to investigate AMH serum levels in patients affected by secondary amenorrhea. The AMH was significantly lower (or undetectable) in patients with premature ovarian failure (POF) and significantly higher in patients affected by polycystic ovary syndrome (PCOS). We suggest that serum AMH evaluation could be associated with that of established hormones, such as FSH, LH, and E2, when the activity of hypothalamo-pituitary-ovarian axis is investigated.
La Marca
Antonio
A
Mother-Infant Department, Institute of Obstetrics and Gynecology, University of Modena and Reggio Emilia, Modena, Italy. antlamarca@libero.it
Pati
Mariangela
M
Orvieto
Raoul
R
Stabile
Gaspare
G
Carducci Artenisio
Alfredo
A
Volpe
Annibale
A
D000293:Adolescent; D000328:Adult; D000568:Amenorrhea / Q000097:blood* / Q000175:diagnosis* / Q000209:etiology; D054304:Anti-Mullerian Hormone; D015415:Biomarkers / Q000097:blood; D005260:Female; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D011085:Polycystic Ovary Syndrome / Q000097:blood* / Q000150:complications / Q000175:diagnosis*; D016649:Primary Ovarian Insufficiency / Q000097:blood* / Q000150:complications / Q000175:diagnosis*; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D013735:Testicular Hormones / Q000097:blood*
D015415:Biomarkers; D006023:Glycoproteins; D013735:Testicular Hormones; D054304:Anti-Mullerian Hormone